Skip to content
Disclosery

Bain Capital Life Sciences Investors, LLC: AVGO position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Bain Capital Life Sciences Investors, LLC on AVGO, newest first. How the timeline and the estimate are built.

Bain Capital Life Sciences Investors, LLC held 0 AVGO shares at 2025-12-31 per its 13F-HR filed 2026-02-17.

the latest 13F is the newest step

  1. period ended2025-12-31
    13F 0 shares
    Change vs previous 13F -8,960 shares

    13F-HR 0001962552-26-000002 filed by Bain Capital Public Equity, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-09-30
    13F 8,960 shares
    Change vs previous 13F +3,400 shares

    1.87% of the 13F portfolio, value $2,955,994.

    13F-HR 0001962552-25-000005 filed by Bain Capital Public Equity, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-06-30
    13F 5,560 shares
    Change vs previous 13F not available

    1.01% of the 13F portfolio, value $1,532,614.

    13F-HR 0001768111-25-000012 filed by Bain Capital Public Equity, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).